Scroll Top

Scenic Biotech joins Michael J. Fox LRRK2 consortium with a novel lysosomal bet on Parkinson’s

European Biotechnology

June 11, 2026

June 10, 2026

https://www.labiotech.eu/in-depth/neurology-technology/

June 9, 2026

https://european-biotechnology.com/latest-news/bial-drops-pariceract-after-phase-iib-failure-in-gba-associated-parkinsons/

May 27, 2026

https://finance.yahoo.com/sectors/healthcare/articles/gain-therapeutics-expands-compelling-evidence-043446986.html